Atrial flutter
Drug research and approvals for atrial flutter: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 18, 2026, 32 studies of atrial flutter are recruiting on ClinicalTrials.gov, Health Canada has authorized 3 drug trials for it since 2013, and FDA has 1 approved and 0 open orphan designations naming it.
- Recruiting worldwide: 32
- Trials authorized in Canada: 3
- FDA orphan approvals: 1
- EU medicines: 0
Recruiting Now
Newest start dates first, of 32 recruiting on ClinicalTrials.gov ↗- MAGNEsium With meToprolol for Rate Control In Atrial FibrillationNCT07632157 · Phase 3 · Wake Forest University Health Sciences · starts Nov 10, 2026
- HeartBeam ECG RegistryNCT07501299 · Not reported · HeartBeam, Inc. · starts Mar 30, 2026
- Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation ProceduresNCT07271238 · Not applicable · LUMA Vision Ltd. · starts Mar 3, 2026
- Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-FlutterNCT06876896 · Not applicable · Wake Forest University Health Sciences · starts Mar 3, 2026
- Anatomical Navigation for Guided Electrophysiology in AFL and AFibNCT07210151 · Not applicable · LUMA Vision Ltd. · starts Jan 29, 2026
- Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency…NCT07002450 · Not applicable · Ottawa Heart Institute Research Corporation · starts Jun 15, 2025
- Intracardiac Echocardiography-Guided Cavotricuspid Isthmus Ablation With a Circular-Shaped Pulsed Field Ablation…NCT07353775 · Not reported · Beijing Anzhen Hospital · starts Jan 15, 2025
- Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal…NCT06402851 · Phase 4 · Hospital Sirio-Libanes · starts Dec 18, 2024
- Genetic Characterization of Patients With Arrhythmia-Induced CardiomyopathyNCT06896266 · Not reported · Hospital Universitario 12 de Octubre · starts Dec 1, 2024
- Pericardiotomy in Cardiac SurgeryNCT06486636 · Not applicable · Population Health Research Institute · starts Oct 21, 2024
Drug Pipeline
2 approved, 8 in phase 3, 5 in phase 2; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Dofetilide, Landiolol
- Dronedarone
- Phase 3 Voltage-gated L-type calcium channel blocker
- Tedisamil
- Phase 3 Voltage-gated potassium channel blocker
- Amiodarone
- Phase 3 HERG blocker
- Vernakalant
- Phase 3 Kir3.1/Kir3.4 blocker
- Ramipril
- Phase 3 Angiotensin-converting enzyme inhibitor
- Warfarin
- Phase 3 Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
- Apixaban
- Phase 3 Coagulation factor X inhibitor
- Ascorbic acid
- Phase 3 Supplement
- Celivarone
- Phase 2 Unknown
- Onabotulinumtoxina
- Phase 2 Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
- Betrixaban
- Phase 2 Coagulation factor X inhibitor
- AZD1305
- Phase 2 HERG blocker
- Vanoxerine
- Phase 2
How Its Trials Ended
192 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 47 whose ending is known, 51% met their primary endpoint, 11% missed it and 38% stopped early.
- Completed, result not reported7841%
- Ongoing4322%
- Met its primary endpoint2413%
- Status unknown2413%
- Stopped: other or unclear116%
- Missed its primary endpoint53%
- Stopped: enrollment or feasibility21%
- Stopped: sponsor or business decision21%
- Stopped: lack of efficacy11%
- Stopped: safety11%
- Stopped: funding11%
Trials Authorized in Canada
Newest first; search them all in Canada trials| Aug 12, 2014 | Genetic-af - a genotype-directed comparative effectiveness trial of bucindolol and and toprol-xl for prevention of symptomatic atrial fibrillation/atrial…bucindolol/ metoprolol | Arca Biopharma Inc | Closed |
| Jul 18, 2014 | Rate control versus rhythm control for postoperative atrial fibrillationAmiodarone | International Center For Health Outcomes And Innovation Research | Ongoing |
| Sep 6, 2013 | Fast (fetal atrial flutter & supraventricular tachycardia) therapy trial - substudy aDigoxin / sotalol | Hospital For Sick Children | Pending |
FDA Orphan Designations
Approved first, then open designations, newest first| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Jul 2, 2009 | So-AqueousFor use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of… | AltaThera Pharmaceuticals LLC | Approved |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA